BIOMAT Database Logo BIOMAT Database Logo

Retraction: Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity. 2023

UI MeSH Term Description Entries

Related Publications

Retraction: Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity.
January 2023, PloS one,
Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
January 2013, PloS one,
CD4+CD25+ regulatory T cells in tumor immunity.
May 2016, International immunopharmacology,
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity.
March 2019, Proceedings of the National Academy of Sciences of the United States of America,
Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
March 2007, Cancer science,
Induction of CD4(+)CD25(+) T regulatory cells with CD103 depletion.
September 2010, The Journal of surgical research,
CD4-mediated functional activation of human CD4+CD25+ regulatory T cells.
May 2007, European journal of immunology,
In vivo depletion of CD4+CD25+ regulatory T cells in cats.
January 2008, Journal of immunological methods,
Naturally arising CD25+CD4+ regulatory T cells in tumor immunity.
January 2005, Current topics in microbiology and immunology,
Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells.
January 2005, Methods in molecular medicine,
Copied contents to your clipboard!